MeSH D009373 - germ cell and embryonal neoplasms
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009370:Neoplasms by histologic type
0 Companies
0 Drugs
Success rate
D009373:
Germ cell and embryonal neoplasms
D002817:Chordoma
0 Companies
0 Drugs
Success rate
D008649:Mesonephroma
0 Companies
0 Drugs
Success rate
D013724:Teratoma
0 Companies
0 Drugs
Success rate
D014328:Trophoblastic neoplasms
D017599:Neuroectodermal tumors
0 Companies
0 Drugs
Success rate
D018236:Embryonal carcinoma
0 Companies
0 Drugs
Success rate
D018237:Germinoma
0 Companies
0 Drugs
Success rate
D018238:Gonadoblastoma
0 Companies
0 Drugs
Success rate
D018243:Teratocarcinoma
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Carboplatin | Carboplatin | 2005-09-21 | |||
| Novast Laboratories | Carboplatin | Carboplatin | 2017-04-26 | |||
| Mylan | Carboplatin | Carboplatin | 2007-04-24 | |||
| NATCO Pharma | Carboplatin | Carboplatin | 2012-05-29 | |||
| Cipla | Carboplatin | Carboplatin | 2006-01-27 | |||
| Sandoz | Carboplatin | Carboplatin | 2005-03-18 | |||
| Sun Pharmaceutical Industries | Carboplatin | Carboplatin | 2008-09-19 | |||
| Hospira | Carboplatin | Carboplatin | 2004-10-27 | |||
| Accord Healthcare | Carboplatin | Carboplatin | 2017-02-09 | |||
| Hikma Pharmaceuticals | Carboplatin | Carboplatin | 2004-10-14 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
55%29/53
Phase 2
38%21/56
Phase 3
23%6/26
Approved: 1Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use